Alcon AG | ALC - Ordinary Share Capital


Alcon AG reported $487.4M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 73K Mar/2026
Bayer EUR 982.42M 0 Dec/2025
Essilor EUR 463.05M 1.9M Dec/2025
Fresenius EUR 563.24M 0 Dec/2025
Fresenius Medical Care EUR 270.09M 9.2M Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
GRIFOLS EUR 680.58M 0 Mar/2026
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Mar/2026
Novartis USD 1.91B 60K Mar/2026
Philips EUR 952.02M 729K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Smith & Nephew USD 875.96M 1.61M Dec/2025
Sonova Holding CHF 59.61M 10.56K Jun/2025
UCB EUR 190.36M 365.15K Dec/2025